Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barnwell, J. M.
Right arrow Articles by Edge, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barnwell, J. M.
Right arrow Articles by Edge, S. B.

Annals of Surgical Oncology, Vol 5, Issue 2 126-130, Copyright © 1998 by Society of Surgical Oncology

ARTICLES

Sentinel node biopsy in breast cancer

J. M. Barnwell, M. A. Arredondo, D. Kollmorgen, J. F. Gibbs, D. Lamonica, W. Carson, P. Zhang, J. Winston and S. B. Edge
Division of Surgical Oncology, Roswell Park Cancer Institute, State University of New York at Buffalo, 14263, USA.

BACKGROUND: Sentinel lymph node biopsy (SNB) in breast cancer may be used in place of axillary lymph node dissection (ALND) if SNB accurately stages the axilla. This study assessed the success and accuracy of axillary SNB with isosulfan blue (ISB) and technetium-99 sulfur colloid (TSC) compared to ALND. METHODS: Forty-two women with T1 or T2 breast cancer underwent SNB and ALND. Sixty to 90 minutes before anesthetic induction, a mixture of 3 mL ISB and 1 mCi TSC was injected around the primary cancer or prior biopsy site. Intraoperatively, the SLN was identified using a gamma detector (Neoprobe 1000) or by visualization of the blue-stained lymph node and afferent lymphatics. The SLN was excised separately, and a level I/II ALND was completed. The histologic findings of the axillary contents and SLN were compared. RESULTS: An axillary SLN was found in 38 of 42 (90%) cases. SLN localization rate and predictive value were the same for women who had and those who had not undergone excisional biopsy before the date of SNB. Fifteen of 42 (36%) patients had lymph node metastases. The SLN was positive in all women with axillary metastases (negative predictive value, 100%). CONCLUSIONS: If confirmed by larger series, a negative SNB may eliminate the need for ALND for select women with breast cancer.


This article has been cited by other articles:


Home page
 JNCI J Natl Cancer InstHome page
S. B. Edge, J. C. Niland, M. A. Bookman, R. L. Theriault, R. Ottesen, E. Lepisto, and J. C. Weeks
Emergence of Sentinel Node Biopsy in Breast Cancer as Standard-of-Care in Academic Comprehensive Cancer Centers
J Natl Cancer Inst, October 15, 2003; 95(20): 1514 - 1521.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
R. Kumar, S. Jana, S. I. Heiba, M. Dakhel, D. Axelrod, B. Siegel, S. Bernik, C. Mills, M. Wallack, and H. M. Abdel-Dayem
Retrospective Analysis of Sentinel Node Localization in Multifocal, Multicentric, Palpable, or Nonpalpable Breast Cancer
J. Nucl. Med., January 1, 2003; 44(1): 7 - 10.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
S. L. Wong, M. J. Edwards, C. Chao, T. M. Tuttle, R. D. Noyes, D. J. Carlson, A. L. Laidley, T. Q. McGlothin, P. B. Ley, C. M. Brown, et al.
The Effect of Prior Breast Biopsy Method and Concurrent Definitive Breast Procedure on Success and Accuracy of Sentinel Lymph Node Biopsy
Ann. Surg. Oncol., April 1, 2002; 9(3): 272 - 277.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
T. W. Bauer, F. R. Spitz, L. S. Callans, A. Alavi, R. Mick, S. P. Weinstein, I. Bedrosian, D. L. Fraker, T. L. Bauer, and B. J. Czerniecki
Subareolar and Peritumoral Injection Identify Similar Sentinel Nodes for Breast Cancer
Ann. Surg. Oncol., March 1, 2002; 9(2): 169 - 176.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
J. Cantin, H. Scarth, M. Levine, and M. Hugi
Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy
Can. Med. Assoc. J., July 1, 2001; 165(2): 166 - 173.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
R. L. Birdwell, K. L. Smith, B. J. Betts, D. M. Ikeda, H. W. Strauss, and S. S. Jeffrey
Breast Cancer: Variables Affecting Sentinel Lymph Node Visualization at Preoperative Lymphoscintigraphy
Radiology, July 1, 2001; 220(1): 47 - 53.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
C. Nos, P. Freneaux, S. Guilbert, M. C. Falcou, R. J. Salmon, and K. B. Clough
Sentinel Lymph Node Detection for Breast Cancer: Which Patients Are Best Suited for the Patent Blue Dye Only Method of Identification?
Ann. Surg. Oncol., June 1, 2001; 8(5): 438 - 443.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
V. J. Kamath, R. Giuliano, E. L. Dauway, A. Cantor, C. Berman, N. N. Ku, C. E. Cox, and D. S. Reintgen
Characteristics of the Sentinel Lymph Node in Breast Cancer Predict Further Involvement of Higher-Echelon Nodes in the Axilla: A Study to Evaluate the Need for Complete Axillary Lymph Node Dissection
Arch Surg, June 1, 2001; 136(6): 688 - 692.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
J. M. Kane III, S. B. Edge, J. S. Winston, N. Watroba, and T. C. Hurd
Intraoperative Pathologic Evaluation of a Breast Cancer Sentinel Lymph Node Biopsy as a Determinant for Synchronous Axillary Lymph Node Dissection
Ann. Surg. Oncol., April 1, 2001; 8(4): 361 - 367.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
M. R. Weiser, L. L. Montgomery, L. K. Tan, B. Susnik, D. Y. H. Leung, P. I. Borgen, and H. S. Cody III
Lymphovascular Invasion Enhances the Prediction of Non-Sentinel Node Metastases in Breast Cancer Patients With Positive Sentinel Nodes
Ann. Surg. Oncol., March 1, 2001; 8(2): 145 - 149.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
H. S. Cody III, J. Fey, T. Akhurst, M. Fazzari, M. Mazumdar, H. Yeung, S. D.J. Yeh, and P. I. Borgen
Complementarity of Blue Dye and Isotope in Sentinel Node Localization for Breast Cancer: Univariate and Multivariate Analysis of 966 Procedures
Ann. Surg. Oncol., January 1, 2001; 8(1): 13 - 19.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
S. K. Boolbol, J. V. Fey, P. I. Borgen, A. S. Heerdt, L. L. Montgomery, M. Paglia, J. A. Petrek, H. S. Cody III, and K. J. Van Zee
Intradermal Isotope Injection: A Highly Accurate Method of Lymphatic Mapping in Breast Carcinoma
Ann. Surg. Oncol., January 1, 2001; 8(1): 20 - 24.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
G Cserni
Axillary staging of breast cancer and the sentinel node
J. Clin. Pathol., October 1, 2000; 53(10): 733 - 741.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
G. Cserni, M. Rajtar, and G. Boross
Blue Nodes Left Behind After Vital Blue Dye-guided Axillary Sentinel Node Biopsy in Breast Cancer Patients
Jpn. J. Clin. Oncol., June 1, 2000; 30(6): 263 - 266.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
R. K. Orr, J. L. Hoehn, and N. F. Col
The Learning Curve for Sentinel Node Biopsy in Breast Cancer: Practical Considerations
Arch Surg, July 1, 1999; 134(7): 764 - 767.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. Reynolds, R. Mick, J. H. Donohue, C. S. Grant, D. R. Farley, L. S. Callans, S. G. Orel, G. L. Keeney, T. J. Lawton, and B. J. Czerniecki
Sentinel Lymph Node Biopsy With Metastasis: Can Axillary Dissection Be Avoided in Some Patients With Breast Cancer?
J. Clin. Oncol., June 1, 1999; 17(6): 1720 - 1720.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
L. Liberman, H. S. Cody III, A. D. K. Hill, P. P. Rosen, S. D. J. Yeh, T. Akhurst, E. A. Morris, A. F. Abramson, P. I. Borgen, and D. D. Dershaw
Sentinel Lymph Node Biopsy after Percutaneous Diagnosis of Nonpalpable Breast Cancer
Radiology, June 1, 1999; 211(3): 835 - 844.
[Abstract] [Full Text]

Home page
 Arch SurgHome page
A. E. Giuliano
Mapping a Pathway for Axillary Staging: A Personal Perspective on the Current Status of Sentinel Lymph Node Dissection for Breast Cancer
Arch Surg, February 1, 1999; 134(2): 195 - 199.
[Full Text] [PDF]

Home page
 NEJMHome page
K. M. McMasters, A. E. Giuliano, M. I. Ross, D. S. Reintgen, K. K. Hunt, D. R. Byrd, V. S. Klimberg, P. W. Whitworth, L. C. Tafra, and M. J. Edwards
Sentinel-Lymph-Node Biopsy for Breast Cancer -- Not Yet the Standard of Care
N. Engl. J. Med., October 1, 1998; 339(14): 990 - 995.
[Full Text]

Home page
 The OncologistHome page
E. C. Hsueh and A. E. Giuliano
Sentinel Lymph Node Technique for Staging of Breast Cancer
Oncologist, June 1, 1998; 3(3): 165 - 170.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the Society of Surgical Oncology.